계명대학교 의학도서관 Repository

Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide

Metadata Downloads
Author(s)
Youngil KohSoo-Mee BangJae Hoon LeeHwi-Joong YoonYoung-Rok DoHun-Mo RyooNari LeeSeok Jin KimKihyun KimSung-Soo YoonJong-Ho WonYeung-Chul MunMoon-Hee LeeKi-Hyun RheeHyo-Jung KimHyeonSeok EomMin Kyoung KimHyun Chun Shin
Keimyung Author(s)
Do, Young Rok
Department
Dept. of Internal Medicine (내과학)
Journal Title
Annals of Hematology
Issued Date
2010
Volume
89
Issue
2
Abstract
The frequency of thromboembolic events (TE) in
Caucasian patients with multiple myeloma (MM) receiving
thalidomide as the initial treatment has been reported to be
10~58% without prophylactic anticoagulation. Korean MM
patients treated with thalidomide were studied to determine
the frequency of TE and associated risk factors. A
retrospective medical record review of the Korean MM
registry from 25 centers in Korea between 2003 and 2007was performed. We assessed the incidence of arterial and
venous TE and the associated clinical parameters. Three
hundred and sixty MM patients (median age 61 years,
range 32–88 years) received thalidomide treatment. Fourteen
patients (3.9%) developed TE: 12 had venous and two
had arterial locations. The sites for the venous TE included
lungs (seven), lower extremities (four), upper extremities
(one), and neck (one). Arterial TE developed in cerebral
and peripheral arteries each. No single clinical parameter
such as prerequisite for the metabolic syndrome, disease
status, and treatment regimen were predictive for the
development of TE. The frequency of TE in patients who
received thalidomide as initial therapy (7/155) was not
different from those who received thalidomide for progressive
or relapsed disease (7/205, p=0.592). The frequency of
TE during thalidomide treatment in Korean patients with
MM was low. No significant clinical factor was found to be
a risk factor. The subgroup requiring thromboprophylaxis
among the Korean patients with MM, receiving thalidomide,
needs to be clarified.
Keywords Multiple myeloma . Thalidomide .
Thromboembolism
Keimyung Author(s)(Kor)
도영록
Publisher
School of Medicine
Citation
Youngil Koh et al. (2010). Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide. Annals of Hematology, 89(2), 201–206. doi: 10.1007/s00277-009-0807-6
Type
Article
ISSN
0939-5555
Source
https://link.springer.com/article/10.1007%2Fs00277-009-0807-6
DOI
10.1007/s00277-009-0807-6
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/34972
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.